Impact on clinical outcomes and health costs of deranged potassium levels in patients with chronic cardiovascular, metabolic, and renal conditions.
Jiménez-Marrero S, Cainzos-Achirica M, Monterde D, Vela E, Cleries M, García-Eroles L, Enjuanes C, Yun S, Garay A, Moliner P, Alcoberro L, Corbella X, Comín-Colet J.
Jiménez-Marrero S, et al. Among authors: monterde d.
Rev Esp Cardiol (Engl Ed). 2021 Apr;74(4):312-320. doi: 10.1016/j.rec.2020.06.013. Epub 2020 Jul 19.
Rev Esp Cardiol (Engl Ed). 2021.
PMID: 32694080
English, Spanish.